Lung Health and Breath Biomarkers: Acute Effects of Inhaled Cannabis
Part of paid clinical trials in Lexington, Kentucky.
- Sponsor
- Hannah Harris
- Study ID
- NCT07694466
- Phase
- EARLY_PHASE1
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Biomarkers
- Cannabis Use
- Tobacco
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 55 Years
- Healthy Volunteers
- Accepted
Interventions
- Cannabis (THC) — DRUGActive Cannabis (THC) will be inhaled.
- Tobacco Cigarette — DRUGA leading brand of tobacco cigarette (\~1.0 gram; Marlboro Gold; Phillip Morris International)
Study Details
This outpatient study examines how inhaled cannabis, combustible or vaporized, alters lung health and breath biomarkers compared to a tobacco cigarette.
Key Dates
- First listed
- Jul 10, 2026
- Start date
- Sep 1, 2026
- Status verified
- Jul 2026
- Primary completion
- Feb 1, 2027
- Completion
- Jun 1, 2027
Study Design
- Enrollment
- 12 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- BASIC_SCIENCE
Arms
- Active Comparator: Tobacco CigaretteParticipants will inhale a leading brand of tobacco cigarette (\~1.0 gram; Marlboro Gold; Phillip Morris International).
- Experimental: Vaporized Cannabis (THC)Participants will receive a non-therapeutic, active vaporized marijuana.
- Experimental: Combustible Cannabis (THC)Participants will receive a non-therapeutic, active smoked marijuana.
Primary Outcome Measure
Exhaled Breath Condensate (EBC) [ Time Frame: Baseline (prior to study drug admission), approximately 25, 40,60, 90, 120 and 180 minutes after drug administration ]
Central Contacts
- Paul A Nuzzo, M.A.859-323-0002
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Kentucky | Lexington | Kentucky | 40508 | - |
Find similar trials in Lexington, KY
By research site
Related Studies
- Cannabis and Opioid Use Disorder, Study 2PHASE1 · Not Yet Recruiting · University of Kentucky · Lexington, Kentucky
- Cannabis Effects on Opioid Self-AdministrationPHASE1 · Not Yet Recruiting · Shanna Babalonis, PhD · Lexington, Kentucky
- Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use DisordersPHASE2 · Recruiting · Medical University of South Carolina · Charleston, South Carolina
- Project e-PBI+ - Parent Intervention to Reduce College Student Drinking and Cannabis UseRecruiting · Penn State University · University Park, Pennsylvania